Latest News & Updates

Breaking News

  • 1 day ago

  • Vaibhavi M.

Axplora Consolidates Global UDCA API Manufacturing at India's Vizag Facility After European Exit
Breaking News
FDA and NIH Launch Three-Part ClinicalTrials.gov Compliance Training for Sponsor-Investigators in July 2026

Vaibhavi M.

Other trending news you may like to read

Axplora Consolidates Global UDCA API Manufacturing at India's Vizag Facility After European Exit

Axplora exits Italian UDCA production, consolidating global API supply at its GMP-certified Vizag facility with capacity and sustainability gains.

Vaibhavi M.

Pharma Now

FDA and NIH Launch Three-Part ClinicalTrials.gov Compliance Training for Sponsor-Investigators in July 2026

FDA and NIH host a three-part virtual training on ClinicalTrials.gov compliance, covering reporting deadlines, PRS functionality, and enforcement risk for sponsor-investigators.

Vaibhavi M.

Pharma Now

Optimi Health Completes First GMP Psilocybin Export to UK for Phase 2 Clinical Trial

Optimi Health ships GMP psilocybin capsules to the UK under dual Health Canada and Home Office authorization, establishing a procedural template for psychedelic clinical supply.

Vaibhavi M.

Pharma Now

FDA Issues Six Drug Safety Communications Requiring Labeling Updates Across OTC, Opioid, and GLP-1 Product Lines

Six FDA Drug Safety Communications issued in 2026 impose labeling obligations across OTC, opioid, and GLP-1 product lines, tightening post-market compliance timelines.

Vaibhavi M.

Pharma Now